InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,418.42
(
-0.28%
)
US TECH 100
19,110.40
(
0.22%
)
Dow Jones
38,473.78
(
-0.45%
)
Brent Oil
82.25
(
0.34%
)
Bitcoin
66,800.37
(
0.06%
)
Post# of 252171
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119832
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 218861

Friday, 05/04/2018 12:55:41 PM

Friday, May 04, 2018 12:55:41 PM

Post# of 252171
RVNC—

1) News of an ex-US partnership for RT002 could come at any time; it does not necessarily have to wait until RVNC submits the MAA for glabellar lines.

2) Yes.

3) On average, FDA reviews of supplemental BLAs are about two months shorter than (original) BLAs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up